A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background: Many individuals with diabetes live in low- or middle-income settings. Glycemic control is challenging, particularly in resource-limited areas that face numerous healthcare barriers. Objective: To compare HbA1c outcomes for individuals randomized to TIME, a T elehealth-supported,I ntegrated care with CHWs (Community Health Workers), and ME dication-access program (intervention) versus usual care (wait-list control). Design: Randomized clinical trial. Participants: Low-income Latino(a) adults with type 2 diabetes. Interventions: TIME consisted of (1) CHW-participant telehealth communication via mobile health (mHealth) for 12 months, (2) CHW-led monthly group visits for 6 months, and (3) weekly CHW-physician diabetes training and support via telehealth (video conferencing). Main Measures: Investigators compared TIME versus control participant baseline to month 6 changes of HbA1c (primary outcome), blood pressure, body mass index (BMI), weight, and adherence to seven American Diabetes Association (ADA) standards of care. CHW assistance in identifying barriers to healthcare in the intervention group were measured at the end of mHealth communication (12 months). Key Results: A total of 89 individuals participated. TIME individuals compared to control participants had significant HbA1c decreases (9.02 to 7.59% (− 1.43%) vs. 8.71 to 8.26% (− 0.45%), respectively,p = 0.002), blood pressure changes (systolic: − 6.89 mmHg vs. 0.03 mmHg,p = 0.023; diastolic: − 3.36 mmHg vs. 0.2 mmHg, respectively,p = 0.046), and ADA guideline adherence (p < 0.001) from baseline to month 6. At month 6, more TIME than control participants achieved> 0.50% HbA1c reductions (88.57% vs. 43.75%,p < 0.001). BMI and weight changes were not significant between groups. Many (54.6%) TIME participants experienced> 1 barrier to care, of whom 91.7% had medication issues. CHWs identified the majority (87.5%) of barriers. Conclusions: TIME participants resulted in improved outcomes including HbA1c. CHWs are uniquely positioned to identify barriers to care particularly related to medications that may have gone unrecognized otherwise. Larger trials are needed to determine the scalability and sustainability of the intervention. Clinical Trial: NCT03394456, accessed at https://clinicaltrials.gov/ct2/show/NCT03394456
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Boateng, G. O., Neilands, T. B., Frongillo, E. A., Melgar-Quiñonez, H. R., & Young, S. L. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00149 · Cited by 5,925 · cited 1×
“9/4 or 1–3/10) and totalled the items to create an overall score.(39) If an item was omitted from a survey, the variable was excluded from analysis.”
BackgroundStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Estimating effect sizes from pretest-posttest-control group designs
Morris, S. B. (2008) · Organizational Research Methods · doi:10.1177/1094428106291059 · Cited by 2,133
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
The impact of mHealth interventions: systematic review of systematic reviews
Marcolino, M. S., Oliveira, J. A. Q., D'Agostino, M., Ribeiro, A. L., Alkmim, M. B. M., & Novillo-Ortiz, D. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.8873 · Cited by 1,163
Maintenance of Lost Weight and Long-Term Management of Obesity
Hall, K. D., & Kahan, S. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.012 · Cited by 876
Scott, K., Beckham, S. W., Gross, M., Pariyo, G., Rao, K. D., Cometto, G., & Perry, H. B. (2018) · Human Resources for Health · doi:10.1186/s12960-018-0304-x · Cited by 732
Palmas, W., March, D., Darakjy, S., Findley, S. E., Teresi, J., Carrasquillo, O., & Luchsinger, J. A. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3247-0 · Cited by 164
Cited by
Anderson, A., O’Connell, S. S., Thomas, C., & Chimmanamada, R. (2022) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01174-6 · Cited by 70
“Only two studies used multi-target interventions as defined by our conceptual framework [33, 38].”
BackgroundHangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., & Udsen, F. W. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211064633 · Cited by 55
Robson, N., & Hosseinzadeh, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212171 · Cited by 55
“Of the 10 studies that had evaluated the effectiveness of mHealth interventions for type 2 diabetes management, 4 studies [5,31,41,42] reported statistically significant changes between the mHealth intervention groups and control groups measured by a reduction in mean HbA1c levels.”
BackgroundMethodInfluentialRecent Findings on the Effectiveness of Peer Support for Patients with Type 2 Diabetes
Werner, J. J., Ufholz, K., & Yamajala, P. (2024) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-024-00737-6 · Cited by 24
Jiang, S., Gao, X., Diao, H., Zhang, Y., Lu, G., Liu, X., & Li, Y. (2026) · JMIR mHealth and uHealth · doi:10.2196/70429 · Cited by 6
Metadata
- Authors
- Vaughan, E. M., Hyman, D. J., Naik, A. D., Samson, S. L., Razjouyan, J., & Foreyt, J. P.
- Venue
- Journal of General Internal Medicine
- Published
- 2020-07-22
- Volume
- 36
- Issue
- 2
- Pages
- 455-463
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- OpenAlex
- W3045486530
- Cited by
- 50
- References
- 10
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial. https://app.cochat.ai/papers/10.1007/s11606-020-06017-4
- The paper
- Vaughan, E. M., Hyman, D. J., Naik, A. D., Samson, S. L., Razjouyan, J., & Foreyt, J. P. (2021). A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-020-06017-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.